期刊文献+

MRP1/CD9在膀胱癌组织中的表达及意义 被引量:2

Expression and significance of MRP1/CD9 in bladder carcinoma
下载PDF
导出
摘要 目的探讨M RP 1/CD 9在膀胱癌组织的表达及其临床意义。方法用免疫组化SP法检测M RP 1/CD 9在膀胱癌组织和正常膀胱黏膜组织中的表达。结果正常膀胱组织中M RP 1/CD 9均为阳性。膀胱癌组织中M RP 1/CD 9表达降低,且与病理分期呈负相关,与临床分期无相关性。结论在膀胱癌组织中M RP 1/CD 9表达降低,可能与膀胱癌的发展有关。其降低程度可以作为评估膀胱癌恶性程度的一个重要指标。 [Objective] To investigate the expression and significance of MRP1/CD9 in bladder carcinoma. [Method] Immunohistochemistry was used to detect the MRP1/CD9 expression in 52 cases with bladder carcinoma and 10 cases of normal bladder tissues. [Result] Positive expression of MRP1/CD9 was detected in 10 (10/10) normal tissue and 27 (27/52) cases of bladder carcinomas. Negative correlation was found between MRP1/CD9 protein expression and pathological grade ( P 〈0.05). There was no statistical significance between MRP1/CD9 expression and clinical tumor stage (P 〉0.05). [Conclusion] MRP1/D9 expression is downregulated in bladder carcinoma and is possible to correlate with progression of bladder carrinma, MRP1/CD9 expression down-regulation degree may be used as an inder for bladder carcinoma malignance.
出处 《山东医药》 CAS 北大核心 2006年第30期17-18,共2页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30371601)
关键词 运动相关蛋白 膀胱肿瘤 跨膜4糖蛋白超家族 motility relative protein bladder neoplasms transmembrane 4 superfamily
  • 相关文献

参考文献5

  • 1Hashida H,Takabayashi A,Tokuhara T,et al.Clinical signi-ficance of transmembrane 4 superfamily in colon cancer[J].Br J Cancer,2003,89(1):158-167.
  • 2Miyake M,Inufusa H,Adachi1 M,et al.Suppression of pulmon-ary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery[J].Oncogene,2000,19(46):5221-5226.
  • 3Mhawech P,Dulguerov P,Tschanz E,et al.Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck[J].Br J Cancer,2004,90(2):471-475.
  • 4Miyamoto S,Maruyama A,Okuqawa K,et al.Loss of Motility-Related Protein 1 (MRP1/CD9) and Integrin alpha3 Expression in Endometrial Cancers[J].Cancer,2001,92(3):542-548.
  • 5Mhawech P,Herrmann F,Coassin M,et al.Motility-Related Protein 1 (MRP-1/CD9) Expression in Urothelial Bladder Carcinoma and its Relation to Tumor Recurrence and Progr-ession[J].Cancer,2003;98(8):1649-1657

同被引文献20

  • 1季润元,沈阳,王成海,孙泽,冯振卿.食管癌组织MRP1/CD9的表达及临床意义[J].中国肿瘤,2004,13(12):812-813. 被引量:1
  • 2夏志军,胡清,王岩,张淑兰,周卓.老年卵巢癌组织中转移抑制基因MRP-1/CD9与integrinsα5的表达特性[J].中国老年学杂志,2007,27(21):2108-2111. 被引量:1
  • 3Maecker HT,Todd SC,Levy S.The tetraspanin superfamily: molecular facilitators. The FASEB Journal . 1997
  • 4Oritani,K,Aoyama,K,Tomiyama,Y,Kincade,PW,Matsuzawa,Y.Stromal cell CD9 and the differentiation of hematopoietic stem/progenitor cells. Leukemia and Lymphoma . 2000
  • 5Uchida S,Shimada Y,Watanabe G,et al.Motility-related protein ( MRP-1/CD9 ) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. British Journal of Cancer . 1999
  • 6Miyake M,Adachi M,Huang C,et al.A novel molecular staging protocol for non-small cell lung cancer. Oncegene . 1999
  • 7Higashiyama,M,Doi,O,Kodama,K,Yokouchi,H,Adachi,M,Huang,CL,Taki,T,Kasugai,T,Ishiguro,S,Nakamori,S,Miyake,M.Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma, its relation to prognosis. International Journal of Cancer . 1997
  • 8Miyake,M,Nakano,K,Itoi,SI.Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Research . 1996
  • 9Sho M,Adachi M,Taki T,et al.Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. International Journal of Cancer . 1998
  • 10Mori,M,Mimori,K,Shiraishi,T.Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clinical Cancer Research . 1998

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部